Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study

The objective of this study was to evaluate the long-term efficacy of venlafaxine extended release (ER) ≤225 mg/ day in patients with recurrent major depressive disorder (MDD). In this double-blind trial, outpatients with recurrent MDD (N=1096) were randomized to 10 weeks of acute-phase treatment wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Kornstein, Susan G., Kocsis, James H., Ahmed, Saeeduddin, Thase, Michael, Friedman, Edward S., Dunlop, Boadie W., Yan, Bing, Pedersen, Ron, Ninan, Philip T., Li, Thomas, Keller, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671869/
https://ncbi.nlm.nih.gov/pubmed/18854724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0b013e328314e2cb
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados